← back to search

Jamie Rossjohn

University of Hong Kong · AU
Area of research
Immunology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, and Monoclonal and Polyclonal Antibodies Research.
h-index
119
citations
48,544
works
982
NIH funding
primary concept
email

Recent publications

Cancer immunotherapy by γδ T cells
Science 2024cited by 75position: middledoi
Diverse cytomegalovirus US11 antagonism and MHC-A evasion strategies reveal a tit-for-tat coevolutionary arms race in hominids
Proceedings of the National Academy of Sciences 2024cited by 5position: middledoi
CD4+ T cell-mediated recognition of a conserved cholesterol-dependent cytolysin epitope generates broad antibacterial immunity
Immunity 2023cited by 15position: middledoi
Atypical sideways recognition of CD1a by autoreactive γδ T cell receptors
Nature Communications 2022cited by 41position: lastdoi
A multilayered immune system through the lens of unconventional T cells
Nature 2021cited by 125position: middledoi
Canonical T cell receptor docking on peptide–MHC is essential for T cell signaling
Science 2021cited by 106position: middledoi
Repeated <i>Plasmodium falciparum</i> infection in humans drives the clonal expansion of an adaptive γδ T cell repertoire
Science Translational Medicine 2021cited by 51position: middledoi
CD1a selectively captures endogenous cellular lipids that broadly block T cell response
The Journal of Experimental Medicine 2021cited by 46position: middledoi
Human skin is colonized by T cells that recognize CD1a independently of lipid
Journal of Clinical Investigation 2021cited by 40position: middledoi
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1
Nature Immunology 2020cited by 260position: middledoi
Human γδ T cells recognize CD1b by two distinct mechanisms
Proceedings of the National Academy of Sciences 2020cited by 65position: middledoi
Virus-Mediated Suppression of the Antigen Presentation Molecule MR1
Cell Reports 2020cited by 52position: middledoi
<i>Nfkb2</i> variants reveal a p100-degradation threshold that defines autoimmune susceptibility
The Journal of Experimental Medicine 2020cited by 31position: middledoi
Peripheral Blood Mucosal-Associated Invariant T Cells in Tuberculosis Patients and Healthy Mycobacterium tuberculosis-Exposed Controls
The Journal of Infectious Diseases 2020cited by 26position: middledoi
Human CD8+ T cell cross-reactivity across influenza A, B and C viruses
Nature Immunology 2019cited by 239position: middledoi
Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease
Cell 2019cited by 191position: middledoi
A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction
Briefings in Bioinformatics 2019cited by 181position: middledoi
IL-23 costimulates antigen-specific MAIT cell activation and enables vaccination against bacterial infection
Science Immunology 2019cited by 120position: middledoi
HLA variation and disease
Nature reviews. Immunology 2018cited by 820position: middledoi
T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids
Nature Immunology 2018cited by 75position: lastdoi
HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome
Nature Communications 2018cited by 53position: middledoi
A T-cell receptor escape channel allows broad T-cell response to CD1b and membrane phospholipids
Nature Communications 2018cited by 35position: middledoi
A molecular basis of human T cell receptor autoreactivity toward self-phospholipids
Science Immunology 2017cited by 50position: lastdoi
Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity
Journal of Clinical Investigation 2016cited by 159position: middledoi
T cell receptor recognition of CD1b presenting a mycobacterial glycolipid
Nature Communications 2016cited by 68position: lastdoi
Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies
Scientific Reports 2016cited by 34position: middledoi
HIV-1–Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection
The Journal of Immunology 2016cited by 31position: middledoi
The burgeoning family of unconventional T cells
Nature Immunology 2015cited by 785position: middledoi
Impairment of immunity to <i>Candida</i> and <i>Mycobacterium</i> in humans with bi-allelic <i>RORC</i> mutations
Science 2015cited by 414position: middledoi
Lipid and small-molecule display by CD1 and MR1
Nature reviews. Immunology 2015cited by 141position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

D. Branch Moody · Boston Medical Center14 papers (2013–2022)Stéphanie Gras · Monash University13 papers (2012–2021)Ildiko Van Rhijn · Utrecht University13 papers (2013–2022)James McCluskey · The University of Melbourne12 papers (2012–2020) · 8 papers (2013–2021)Dale I. Godfrey · Australian Research Council8 papers (2012–2015)Lars Kjer‐Nielsen · The University of Melbourne6 papers (2012–2020)John D. Altman · Emory University6 papers (2013–2021)Zhenjun Chen · Peter Doherty Institute6 papers (2012–2019)David A. Price · London School of Hygiene & Tropical Medicine5 papers (2012–2023)John J. Miles · University of Kansas5 papers (2012–2016)Lyudmila Kostenko · Ministry of Culture5 papers (2012–2019)Alexandra J. Corbett · The University of Melbourne5 papers (2012–2020)Jérôme Le Nours · Monash University5 papers (2012–2022)David P. Fairlie · Human Growth Foundation5 papers (2012–2020)Anthony W. Purcell · Discovery Institute4 papers (2012–2019)Ligong Liu · The University of Queensland4 papers (2012–2020)Mugdha Bhati · Monash University4 papers (2012–2016)Ania Skowera · University College Birmingham4 papers (2012–2016)Linda Wooldridge · University of Bristol4 papers (2012–2016)